This is a routine AGM notice with a single governance resolution. No immediate trading catalyst. Monitor the AGM outcome on September 8, 2026 for any subsequent board changes or strategic shifts, but no price-moving information is present here.
Price Chart
Executive Summary
NovaBridge Biosciences filed a 6-K on July 24, 2026, announcing its Annual General Meeting (AGM) scheduled for September 8, 2026. The sole resolution on the agenda is the removal of director Ms. Xin Liu, which the Board recommends shareholders vote 'FOR,' citing governance optimization. This is a routine administrative filing with no financial data or operational updates, and the director removal, while notable, is a governance matter without disclosed financial impact.
Key Facts
- AGM scheduled for September 8, 2026 in Shanghai.
- Record date for voting is July 27, 2026.
- Sole resolution: removal of director Ms. Xin Liu, recommended by the Board.
- No financial results, guidance, or material business updates provided.
- Filing references the 2025 annual report on Form 20-F already filed.
Financial Impact
No financial figures disclosed in this filing.
Risk Factors
- Director removal could signal internal governance friction, though Board supports the move.
- No operational or financial updates reduce near-term trading relevance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 16 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (NBP) — Batch item 1 | 0001193125-26-316242 |
| Document: 6-k_-_2026_agm.htm | 0001193125-26-316242 |
| Document: nbp-ex99_3.htm | 0001193125-26-316242 |
| Document: nbp-ex99_1.htm | 0001193125-26-316242 |
| Document: nbp-ex99_2.htm | 0001193125-26-316242 |
| Document: 0001193125-26-316242-index-headers.html | 0001193125-26-316242 |
| Document: 0001193125-26-316242-index.html | 0001193125-26-316242 |
| Document: 0001193125-26-316242.txt | 0001193125-26-316242 |
| 6-K Filing (NBP) — Batch item 9 | 0001193125-26-316242 |
| Document: 6-k_-_2026_agm.htm | 0001193125-26-316242 |
| Document: nbp-ex99_3.htm | 0001193125-26-316242 |
| Document: nbp-ex99_1.htm | 0001193125-26-316242 |
| Document: nbp-ex99_2.htm | 0001193125-26-316242 |
| Document: 0001193125-26-316242-index-headers.html | 0001193125-26-316242 |
| Document: 0001193125-26-316242-index.html | 0001193125-26-316242 |
| Document: 0001193125-26-316242.txt | 0001193125-26-316242 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $1.49 | awaiting T+5 | — | $1.25 (−15.77%) |
Oct 25, 2026 2d ago | Press Release | $1.42 | awaiting T+5 | — | $1.25 (−11.62%) |
Oct 23, 2026 4d ago | 6-K | $1.37 | awaiting T+5 | — | $1.25 (−8.39%) |
Oct 13, 2026 14d ago | 6-K | $1.29 $1.43 | ▲ +10.47% | ▲ +11.62% | $1.25 (−2.71%) |
Sep 8, 2026 7w ago | 6-K | $1.78 $1.61 | ▼ −9.55% | ▼ −8.89% | $1.25 (−29.49%) |
Sep 8, 2026 7w ago | 6-K | $1.78 $1.61 | ▼ −9.55% | ▼ −8.89% | $1.25 (−29.49%) |
Aug 20, 2026 9w ago | 6-K | $1.91 $1.89 | ▲ +1.05% | ▲ +2.16% | $1.25 (+34.29%) |
Aug 20, 2026 9w ago | 6-K | $1.91 $1.89 | ▼ −1.05% | ▼ −2.16% | $1.25 (−34.29%) |
Aug 20, 2026 9w ago | Press Release | $1.91 $1.89 | ▲ +1.05% | ▲ +2.16% | $1.25 (+34.29%) |
Jul 24, 2026 13w ago | 6-K | $1.78 $1.60 | ▼ −10.11% | ▼ −11.19% | $1.25 (−29.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers